Conversely, a series of studies by our group suggest that patients with NAFLD have normal GLP-1 and GIP plasma levels, even though they exhibit a reduced incretin effect (32). The gene discussed is GCG; the disease is metabolic dysfunction-associated steatotic liver disease.